These results indicate that by targeting the EGFR on the HNSCC cells, hDT806 disrupts EGFR signaling and its downstream effectors, which may lead to inhibition in cell proliferation in HNSCC cells. This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.